Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMX0PWV)

Drug Name

Anti-IL-23 Drug Info

Synonyms

Anti-IL-23 (chronic inflammation); Anti-IL-23 (chronic inflammation), Merck & Co; Anti-IL-23 (chronic inflammation), Schering-Plough; Anti-interleukin-23 antibody (chronic inflammation), Merck & Co

Indication

Disease Entry	ICD 11	Status	REF
Inflammation	1A00-CA43.1	Phase 3	[1]

Cross-matching ID

TTD Drug ID: DMX0PWV

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Interleukin 23 receptor (IL23R)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ADC-1012	DMJQM7H	Solid tumour/cancer	2A00-2F9Z	Investigative	[2]
FM-303	DMZRI6H	Inflammatory bowel disease	DD72	Investigative	[2]
APG-2305	DMBSDTR	Autoimmune diabetes	5A10	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin 23 receptor (IL23R)	TT6H4QR	IL23R_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of Merck.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2293).